PhentolamineMesylate CAS:65-28-1
Catalog Number | XD96152 |
Product Name | PhentolamineMesylate |
CAS | 65-28-1 |
Molecular Formula | C18H23N3O4S |
Molecular Weight | 377.46 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
Phentolamine mesylate is a medication belonging to the class of alpha-adrenergic blocking agents. It is primarily used in the treatment of conditions such as hypertension (high blood pressure) and pheochromocytoma (a rare tumor in the adrenal glands).One of the main effects of phentolamine mesylate is its ability to block the action of alpha-adrenergic receptors. These receptors are found on smooth muscle cells in blood vessels and are responsible for constricting the vessels, resulting in increased vascular tone and elevated blood pressure. By blocking these receptors, phentolamine mesylate causes relaxation of the smooth muscles, leading to vasodilation and a subsequent reduction in blood pressure. This effect makes it an effective medication for the management of hypertension.Phentolamine mesylate is also utilized in the treatment of pheochromocytoma, a condition characterized by excessive release of catecholamines (epinephrine and norepinephrine) from the adrenal glands. These hormones can cause severe hypertension and other symptoms. Phentolamine mesylate acts by blocking the alpha-adrenergic receptors in the blood vessels, preventing the vasoconstrictive effects of the catecholamines. This helps to normalize blood pressure and relieve symptoms associated with pheochromocytoma.Furthermore, phentolamine mesylate has been used in certain surgical procedures, specifically during the removal of certain tumors called neurofibromas. These tumors can cause compression of nearby blood vessels and nerves, leading to pain and other complications. By injecting phentolamine mesylate into the affected area, it can reduce blood vessel constriction and alleviate pain associated with neurofibromas.It is important to note that phentolamine mesylate may cause side effects, such as dizziness, fast heartbeat, and nasal congestion. It may also interact with other medications, so it is essential to disclose all current medications to the healthcare provider before starting therapy. Additionally, phentolamine mesylate should be used with caution in patients with certain medical conditions, such as coronary artery disease or impaired liver or kidney function.In conclusion, phentolamine mesylate is an alpha-adrenergic blocking agent used primarily for the management of hypertension and pheochromocytoma. Its ability to block alpha-adrenergic receptors results in vasodilation and a subsequent reduction in blood pressure. It is also employed during certain surgical procedures to relieve pain associated with neurofibromas. Like any medication, phentolamine mesylate may cause side effects and interactions, so it should be used under appropriate medical supervision.